Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all. James Simon, M.D., clinical professor of Obstetrics and Gynecology in the School of Medicine and Health Sciences, says estrogen promotes the growth of almost everything, including undetectable tumors in the breasts.
Considering Hormone Replacement Therapy?
Latest News
Pedro Gazzinelli Guimarães, PhD, assistant professor of microbiology, immunology, and tropical medicine, was recently named among the “New Voices in Microbiology” by the journal Infection and Immunity.
Congratulations Anelia Horvath, PhD, on wining the NCI R25 Award!
Members of the GW School of Medicine and Health Sciences (SMHS) Physician Assistant (PA) Program and the James K. Tolton Society recently visited McKinley Technology High School in Northeast Washington, D.C., for a Project Access, an outreach and recruitment program developed by the PA Education…
